tirzepatide weight loss clinical trial results for Obesity Treatment and Diabetes Prevention Tirzepatide Weight Loss Results: What

En los ensayos clnicos, Wegovy ha demostrado su capacidad para ayudar a las personas a perder hasta un 15% de su peso corporal en aproximadamente 16 semanas, lo que lo convierte en una opcin eficaz para aquellos con obesidad o sobrepeso que enfrentan comorbilidades como la diabetes tipo 2, hipertensin, o apnea del sueo

When a plan feels manageable, and your body tolerates it well, its much easier to stay consistent

Public health experts widely agree that GLP-1s are only one part of an effective weight loss program that includes nutrition and lifestyle changes

Consider the risk of untreated depression when discontinuing or changing treatment with antidepressant medication during pregnancy and postpartum